Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;55(2):324-335.
doi: 10.1007/s43441-020-00217-0. Epub 2020 Sep 29.

Development and Application of a Patient Group Engagement Prioritization Tool for Use in Medical Product Development

Affiliations

Development and Application of a Patient Group Engagement Prioritization Tool for Use in Medical Product Development

Brian Perry et al. Ther Innov Regul Sci. 2021 Mar.

Abstract

Introduction: Patient group engagement is increasingly used to inform the design, conduct, and dissemination of clinical trials and other medical research activities. However, the priorities of industry sponsors and patient groups differ, and there is currently no framework to help these groups identify mutually beneficial engagement activities.

Methods: We conducted 28 qualitative, semi-structured interviews with representatives from research sponsor organizations (n = 14) and patient groups (n = 14) to determine: (1) how representatives define benefits and investments of patient group engagement in medical product development, and (2) to refine a list of 31 predefined patient group engagement activities.

Results: Patient group and sponsor representatives described similar benefits: engagement activities can enhance the quality and efficiency of clinical trials by improving patient recruitment and retention, reduce costs, and help trials meet expectations of regulators and payers. All representatives indicated that investments include both dedicated staff time and expertise, and financial resources. Factors to consider when evaluating benefits and investments were also identified as were suggestions for clarifying the list of engagement activities.

Discussion: Using these findings, we refined the 31 engagement activities to 24 unique activities across the medical product development lifecycle. We also developed a web-based prioritization tool ( https://prioritizationtool.ctti-clinicaltrials.org/ ) to help clinical research sponsors and patient groups identify high-priority engagement activities. Use of this tool can help sponsors and patient groups identify the engagement activities that they believe will provide the most benefit for the least investment and may lead to more meaningful and mutually beneficial partnerships in medical product development.

Keywords: Patient engagement; Patient engagement activities; Patient group engagement; Prioritization tool; Stakeholder engagement.

PubMed Disclaimer

Conflict of interest statement

Dr. Levitan is an employee of Janssen Research and Development, LLC. He is a stockholder in Johnson & Johnson and in a portfolio that at times includes other pharmaceutical and health care-related companies. The other co-author(s) have no conflicts of interest do disclose with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1
Figure 1
Refined List of Patient Group Engagement Activities.
Figure 2
Figure 2
Step 1—Identify Fit-for-Purpose Patient Engagement Activities.
Figure 3
Figure 3
Step 2—Evaluate Level of Benefit and Investment of Each Patient Engagement Activity.
Figure 4
Figure 4
Visualize Patient Engagment Activities Within a Priority Matrix.

References

    1. Forsythe LP, Carman KL, Szydlowski V, et al. patient engagement in research: early findings from the Patient-Centered Outcomes Research Institute. Health Aff (Millwood) 2019;38:359–367. doi: 10.1377/hlthaff.2018.05067. - DOI - PubMed
    1. Fischer MA, Asch SM. The future of the Patient-Centered Outcomes Research Institute (PCORI) J Gen Intern Med. 2019;34:2291–2292. doi: 10.1007/s11606-019-05324-9. - DOI - PMC - PubMed
    1. Smith SK, Selig W, Harker M, et al. Patient engagement practices in clinical research among patient groups, industry, and academia in the United States: A Survey. PLoS ONE. 2015;10:e0140232. doi: 10.1371/journal.pone.0140232. - DOI - PMC - PubMed
    1. Levitan B, Getz K, Eisenstein EL, et al. Assessing the financial value of patient engagement: a quantitative approach from CTTI's patient groups and clinical trials project. Ther Innov Regul Sci. 2018;52:220–229. doi: 10.1177/2168479017716715. - DOI - PMC - PubMed
    1. Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines: a call for action. Ther Innov Regul Sci. 2015;49:929–939. doi: 10.1177/2168479015580384. - DOI - PMC - PubMed

Publication types

LinkOut - more resources